Andromed, Inc.
Medical device maker completes sale of principal assets
Published in Cardiovascular Business Week, January 24th, 2006
The transaction specifically involves all tangible and intangible assets related to Androsonix, a unique bioacoustic sensor, Androflo, which measures respiratory rate based on sounds from the trachea, Androgram, which estimates pulmonary artery pressure based on heart sounds and Androscope, a line of electronic stethoscopes that amplifies and filters biological sounds.
After the transaction, Andromed will pursue its activities on a limited basis to preserve its cash and will seek out opportunities to enhance the value of its shares. The company is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- eResearchTechnology, Inc.
ECG services company signs $12.4 million in cardiac monitoring contracts since last update - MedicalCV, Inc.
Device manufacturer enters into preferred purchase agreements with six stock holders - Medicure Inc.
Drug discovery company enters bought deal financing to issue 6.5 million shares - Medwave, Inc.
Blood pressure measuring solutions company announces annual revenue growth of 36%
Reduced atrial fibrillation incidence with enalapril yields cost and health benefits- Acusphere, Inc.
Phase III trial of AI-700 in patients with cardiovascular disease enrolls 700 patients - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
